NATF strives to bring you the most relevant information in the field of thrombosis research and cardiovascular-related illnesses, which includes topics on thrombosis, stroke prevention, atrial fibrillation, and acute coronary syndrome.

Celebration of Gratitude 2017

Please enjoy this video highlighting the important work of NATF’s support group program. On Wednesday, October 18, NATF hosted its…

PERT: A New Model of Care

Updated January 2020 When Mark went to the hospital, he had never heard of a pulmonary embolism (PE). But at…

The EINSTEIN Choice Trial

Dr. Jeffrey Weitz discusses the implications of the EINSTEIN Choice Trial during NATF’s August 2017 online support group.  

A Look at Lymphedema

Updated January 2020 Lymphedema is a serious health issue that many people live with but it’s often misunderstood. Lymphedema develops…

A DOAC Deep Dive: Dabigatran

Updated January 2020 For the past several decades, warfarin has been the go-to anticoagulant drug, but newer treatments have emerged…

Research Report: One Brave Idea

Updated January 2020 Heart disease kills over 600,000 people in the United States every year, accounting for 1 in every…